nodes	percent_of_prediction	percent_of_DWPC	metapath
Melphalan—Chlorambucil—GSTP1—amyotrophic lateral sclerosis	0.0595	0.961	CrCbGaD
Melphalan—Respiratory distress—Riluzole—amyotrophic lateral sclerosis	0.0397	0.0492	CcSEcCtD
Melphalan—Blood creatine phosphokinase increased—Riluzole—amyotrophic lateral sclerosis	0.0367	0.0455	CcSEcCtD
Melphalan—Interstitial lung disease—Riluzole—amyotrophic lateral sclerosis	0.0356	0.0442	CcSEcCtD
Melphalan—Skin ulcer—Riluzole—amyotrophic lateral sclerosis	0.0324	0.0402	CcSEcCtD
Melphalan—Amenorrhoea—Riluzole—amyotrophic lateral sclerosis	0.0287	0.0356	CcSEcCtD
Melphalan—Ulcer—Riluzole—amyotrophic lateral sclerosis	0.0267	0.0331	CcSEcCtD
Melphalan—Hepatocellular injury—Riluzole—amyotrophic lateral sclerosis	0.0252	0.0313	CcSEcCtD
Melphalan—Injection site reaction—Riluzole—amyotrophic lateral sclerosis	0.0251	0.0311	CcSEcCtD
Melphalan—Neoplasm—Riluzole—amyotrophic lateral sclerosis	0.0228	0.0283	CcSEcCtD
Melphalan—SLC22A3—Synaptic Vesicle Pathway—UNC13A—amyotrophic lateral sclerosis	0.0215	0.199	CbGpPWpGaD
Melphalan—Atrial fibrillation—Riluzole—amyotrophic lateral sclerosis	0.0193	0.024	CcSEcCtD
Melphalan—Hyponatraemia—Riluzole—amyotrophic lateral sclerosis	0.0184	0.0228	CcSEcCtD
Melphalan—Cardiac arrest—Riluzole—amyotrophic lateral sclerosis	0.0174	0.0216	CcSEcCtD
Melphalan—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.0169	0.021	CcSEcCtD
Melphalan—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.015	0.0186	CcSEcCtD
Melphalan—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.0148	0.0184	CcSEcCtD
Melphalan—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.0138	0.0172	CcSEcCtD
Melphalan—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.0138	0.0171	CcSEcCtD
Melphalan—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.0138	0.0171	CcSEcCtD
Melphalan—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.0133	0.0166	CcSEcCtD
Melphalan—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.0127	0.0158	CcSEcCtD
Melphalan—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.0127	0.0157	CcSEcCtD
Melphalan—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.0127	0.0157	CcSEcCtD
Melphalan—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.0125	0.0155	CcSEcCtD
Melphalan—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.0124	0.0154	CcSEcCtD
Melphalan—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.0124	0.0154	CcSEcCtD
Melphalan—SLC7A5—Amino acid and oligopeptide SLC transporters—SLC1A2—amyotrophic lateral sclerosis	0.0122	0.113	CbGpPWpGaD
Melphalan—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.0114	0.0142	CcSEcCtD
Melphalan—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.0114	0.0142	CcSEcCtD
Melphalan—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.0113	0.014	CcSEcCtD
Melphalan—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.0112	0.0139	CcSEcCtD
Melphalan—SLC7A5—Amino acid and oligopeptide SLC transporters—SLC1A3—amyotrophic lateral sclerosis	0.0104	0.0964	CbGpPWpGaD
Melphalan—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.0102	0.0126	CcSEcCtD
Melphalan—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00987	0.0122	CcSEcCtD
Melphalan—Cough—Riluzole—amyotrophic lateral sclerosis	0.00962	0.0119	CcSEcCtD
Melphalan—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00956	0.0118	CcSEcCtD
Melphalan—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00939	0.0116	CcSEcCtD
Melphalan—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00939	0.0116	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00932	0.0116	CcSEcCtD
Melphalan—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.009	0.0112	CcSEcCtD
Melphalan—Oedema—Riluzole—amyotrophic lateral sclerosis	0.009	0.0112	CcSEcCtD
Melphalan—Infection—Riluzole—amyotrophic lateral sclerosis	0.00894	0.0111	CcSEcCtD
Melphalan—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00881	0.0109	CcSEcCtD
Melphalan—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00878	0.0109	CcSEcCtD
Melphalan—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00874	0.0108	CcSEcCtD
Melphalan—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00858	0.0106	CcSEcCtD
Melphalan—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00841	0.0104	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.0082	0.0102	CcSEcCtD
Melphalan—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00808	0.01	CcSEcCtD
Melphalan—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00802	0.00995	CcSEcCtD
Melphalan—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00792	0.00983	CcSEcCtD
Melphalan—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00782	0.0097	CcSEcCtD
Melphalan—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00777	0.00964	CcSEcCtD
Melphalan—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00776	0.00962	CcSEcCtD
Melphalan—Pain—Riluzole—amyotrophic lateral sclerosis	0.0077	0.00955	CcSEcCtD
Melphalan—SLC7A5—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A2—amyotrophic lateral sclerosis	0.00719	0.0668	CbGpPWpGaD
Melphalan—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00715	0.00887	CcSEcCtD
Melphalan—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00663	0.00822	CcSEcCtD
Melphalan—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00646	0.00801	CcSEcCtD
Melphalan—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00637	0.0079	CcSEcCtD
Melphalan—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00616	0.00764	CcSEcCtD
Melphalan—SLC7A5—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A3—amyotrophic lateral sclerosis	0.00611	0.0568	CbGpPWpGaD
Melphalan—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00572	0.0071	CcSEcCtD
Melphalan—Rash—Riluzole—amyotrophic lateral sclerosis	0.00568	0.00704	CcSEcCtD
Melphalan—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00567	0.00703	CcSEcCtD
Melphalan—SLC22A3—tongue—amyotrophic lateral sclerosis	0.00545	0.227	CbGeAlD
Melphalan—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00535	0.00663	CcSEcCtD
Melphalan—SLC22A3—Synaptic Vesicle Pathway—SLC1A3—amyotrophic lateral sclerosis	0.00512	0.0476	CbGpPWpGaD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.00321	0.0298	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—KIFAP3—amyotrophic lateral sclerosis	0.00293	0.0272	CbGpPWpGaD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.00273	0.0254	CbGpPWpGaD
Melphalan—SLC22A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—amyotrophic lateral sclerosis	0.00273	0.0254	CbGpPWpGaD
Melphalan—SLC7A5—medulla oblongata—amyotrophic lateral sclerosis	0.00269	0.112	CbGeAlD
Melphalan—SLC22A3—embryo—amyotrophic lateral sclerosis	0.00261	0.109	CbGeAlD
Melphalan—SLC7A5—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00253	0.0235	CbGpPWpGaD
Melphalan—SLC7A5—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.00244	0.0226	CbGpPWpGaD
Melphalan—Ibuprofen—PTGS2—amyotrophic lateral sclerosis	0.00242	0.039	CrCbGaD
Melphalan—SLC7A5—spinal cord—amyotrophic lateral sclerosis	0.0024	0.1	CbGeAlD
Melphalan—SLC7A5—Hemostasis—TUBA4A—amyotrophic lateral sclerosis	0.00203	0.0188	CbGpPWpGaD
Melphalan—SLC7A5—nervous system—amyotrophic lateral sclerosis	0.00202	0.0843	CbGeAlD
Melphalan—SLC7A5—central nervous system—amyotrophic lateral sclerosis	0.00195	0.0811	CbGeAlD
Melphalan—SLC7A5—cerebellum—amyotrophic lateral sclerosis	0.0019	0.0793	CbGeAlD
Melphalan—SLC7A5—Hemostasis—RAB5A—amyotrophic lateral sclerosis	0.00189	0.0175	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—PFN1—amyotrophic lateral sclerosis	0.00183	0.017	CbGpPWpGaD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.00164	0.0152	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00163	0.0152	CbGpPWpGaD
Melphalan—SLC7A5—brain—amyotrophic lateral sclerosis	0.00155	0.0644	CbGeAlD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.00139	0.0129	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.00139	0.0129	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.00139	0.0129	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00129	0.012	CbGpPWpGaD
Melphalan—SLC22A3—nervous system—amyotrophic lateral sclerosis	0.00126	0.0523	CbGeAlD
Melphalan—SLC22A3—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.00124	0.0115	CbGpPWpGaD
Melphalan—SLC7A5—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.00124	0.0115	CbGpPWpGaD
Melphalan—SLC22A3—central nervous system—amyotrophic lateral sclerosis	0.00121	0.0504	CbGeAlD
Melphalan—SLC22A3—brain—amyotrophic lateral sclerosis	0.00096	0.04	CbGeAlD
Melphalan—SLC7A5—Hemostasis—SOD1—amyotrophic lateral sclerosis	0.000883	0.0082	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000832	0.00772	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000798	0.00741	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000798	0.00741	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	0.000792	0.00736	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00073	0.00678	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000707	0.00657	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000707	0.00657	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000678	0.0063	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000638	0.00592	CbGpPWpGaD
Melphalan—SLC22A3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.00063	0.00585	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—DAO—amyotrophic lateral sclerosis	0.000577	0.00536	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—IGF1—amyotrophic lateral sclerosis	0.000539	0.005	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000437	0.00406	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—GSR—amyotrophic lateral sclerosis	0.000403	0.00375	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—VEGFA—amyotrophic lateral sclerosis	0.000352	0.00327	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000331	0.00308	CbGpPWpGaD
Melphalan—SLC7A5—Hemostasis—TP53—amyotrophic lateral sclerosis	0.000266	0.00247	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000178	0.00165	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000164	0.00152	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—APOE—amyotrophic lateral sclerosis	0.000135	0.00125	CbGpPWpGaD
Melphalan—SLC22A3—Metabolism—PTGS2—amyotrophic lateral sclerosis	9.22e-05	0.000857	CbGpPWpGaD
